Descriptive epidemiology of somatising tendency: findings from the CUPID study. by Vargas-Prada, Sergio et al.
eCommons@AKU
Community Health Sciences Department of Community Health Sciences
April 2016
Descriptive epidemiology of somatising tendency:
findings from the CUPID study.
Sergio Vargas-Prada
Universitat Pompeu Fabra, Barcelona, Spain
David Coggon
University of Southampton, Southampton, United Kingdom
Georgia Ntani
University of Southampton, Southampton, United Kingdom
Georgia Ntani
University of Southampton, Southampton, United Kingdom
Karen Walker-Bone
University of Southampton, Southampton, United Kingdom
See next page for additional authors
Follow this and additional works at: http://ecommons.aku.edu/pakistan_fhs_mc_chs_chs
Part of the Family Medicine Commons, and the Public Health Commons
Recommended Citation
Vargas-Prada, S., Coggon, D., Ntani, G., Ntani, G., Walker-Bone, K., Palmer, K. T., Felli, V. E., Harari, R., Barrero, L. H., Felknor, S. A.,
Gimeno, D., Cattrell, A., Bonzini, M., Solidaki, E., Merisalu, E., Habib, R. R., Sadeghian, F., Kadir, M., Warnakulasuriya, S. S.,
Matsudaira, K., Nyantumbu, B., Sim, M. R., Harcombe, H., Cox, K., Sarquis, L. M., Marziale, M. H., Harari, F., Freire, R., Harari, N.,
Monroy, M. V., Quintana, L. A., Rojas, M., Harris, E. C., Serra, C., Martinez, J. M., Delclos, G., Benavides, F. G., Carugno, M., Ferrario,
M. M., Pesatori, A. C., Chatzi, L., Bitsios, P., Kogevinas, M., Oha, K., Freimann, T., Sadeghian, A., Peiris-John, R. J., Sathiakumar, N.,
Wickremasinghe, A. R., Yoshimura, N., Kelsall, H. L., Hoe, V. C., Urquhart, D. M., Derrett, S., McBride, D., Herbison, P., Gray, A., Vega,
E. J. (2016). Descriptive epidemiology of somatising tendency: findings from the CUPID study.. PLoS ONE, 11(4), 1-17.
Available at: http://ecommons.aku.edu/pakistan_fhs_mc_chs_chs/333
Authors
Sergio Vargas-Prada, David Coggon, Georgia Ntani, Georgia Ntani, Karen Walker-Bone, Keith T. Palmer,
Vanda E. Felli, Raul Harari, Lope H. Barrero, Sarah A. Felknor, David Gimeno, Anna Cattrell, Matteo Bonzini,
Eleni Solidaki, Eda Merisalu, Rima R. Habib, Farideh Sadeghian, Muhammad Masood Kadir, Sudath S. P.
Warnakulasuriya, Ko Matsudaira, Busisiwe Nyantumbu, Malcolm R. Sim, Helen Harcombe, Ken Cox, Leila
M. M. Sarquis, Maria H. Marziale, Florencia Harari, Rocio Freire, Natalia Harari, Magda V. Monroy, Leonardo
A. Quintana, Marianela Rojas, E. Clare Harris, Consol Serra, J. Miguel Martinez, George Delclos, Fernando G.
Benavides, Michele Carugno, Marco M. Ferrario, Angela C. Pesatori, Leda Chatzi, Panos Bitsios, Manolis
Kogevinas, Kristel Oha, Tiina Freimann, Ali Sadeghian, Roshini J. Peiris-John, Nalini Sathiakumar, A. Rajitha
Wickremasinghe, Noriko Yoshimura, Helen L. Kelsall, Victor C. W. Hoe, Donna M. Urquhart, Sarah Derrett,
David McBride, Peter Herbison, Andrew Gray, and Eduardo J. Salazar Vega
This article is available at eCommons@AKU: http://ecommons.aku.edu/pakistan_fhs_mc_chs_chs/333
RESEARCH ARTICLE
Descriptive Epidemiology of Somatising
Tendency: Findings from the CUPID Study
Sergio Vargas-Prada1,2,3, David Coggon4,5*, Georgia Ntani4,5, KarenWalker-Bone4,5, Keith
T. Palmer4,5, Vanda E. Felli6, Raul Harari7, Lope H. Barrero8, Sarah A. Felknor9,10,
David Gimeno9, Anna Cattrell11, Matteo Bonzini12, Eleni Solidaki13, EdaMerisalu14, Rima
R. Habib15, Farideh Sadeghian16, M. Masood Kadir17, Sudath S. P. Warnakulasuriya18,
KoMatsudaira19, Busisiwe Nyantumbu20,21, MalcolmR. Sim22, Helen Harcombe23, Ken Cox4,
Leila M. M. Sarquis24, Maria H. Marziale25, Florencia Harari7, Rocio Freire7, Natalia Harari7,
Magda V. Monroy8, LeonardoA. Quintana8, Marianela Rojas26, E. Clare Harris4,5,
Consol Serra1,2,3,27, J. Miguel Martinez28, George Delclos1,2,3,9, Fernando G. Benavides1,2,3,
Michele Carugno29, Marco M. Ferrario12, Angela C. Pesatori29,30, Leda Chatzi13,
PanosBitsios31, Manolis Kogevinas2,3,32, Kristel Oha33, Tiina Freimann34, Ali Sadeghian35,
Roshini J. Peiris-John36,37, Nalini Sathiakumar38, A. RajithaWickremasinghe39,
Noriko Yoshimura40, Helen L. Kelsall22, Victor C. W. Hoe41, Donna M. Urquhart22,
Sarah Derrett42, DavidMcBride23, Peter Herbison23, AndrewGray23, Eduardo J.
Salazar Vega43
1 Center for Research in Occupational Health (CiSAL), Universitat Pompeu Fabra, Barcelona, Spain,
2 CIBER of Epidemiology and Public Health, Barcelona, Spain, 3 IMIM (Hospital del Mar Research Institute),
Barcelona, Spain, 4 Medical Research Council Lifecourse Epidemiology Unit, University of Southampton,
Southampton, United Kingdom, 5 Arthritis Research UK/MRC Centre for Musculoskeletal Health andWork,
University of Southampton, Southampton, United Kingdom, 6 School of Nursing, University of São Paulo,
São Paulo, Brazil, 7 Corporación para el Desarrollo de la Producción y el Medio Ambiente Laboral–IFA
(Institute for the Development of Production and theWork Environment), Quito, Ecuador, 8 Department of
Industrial Engineering, School of Engineering, Pontificia Universidad Javeriana, Bogotá, Colombia,
9 Southwest Center for Occupational and Environmental Health, The University of Texas Health Science
Center at Houston School of Public Health, Houston, Texas, United States of America, 10 Center for Disease
Control and Prevention/National Institute for Occupational Safety and Health, Atlanta, Georgia, United States
of America, 11 North East London NHS Foundation Trust, Goodmayes Hospital, Ilford, United Kingdom,
12 Epidemiology and Preventive Medicine Research Center, University of Insubria, Varese, Italy,
13 Department of Social Medicine, Medical School, University of Crete, Heraklion, Greece, 14 Institute of
Technology, Estonian University of Life Sciences, Tartu, Estonia, 15 Department of Environmental Health,
Faculty of Health Sciences, American University of Beirut, Beirut, Lebanon, 16 Department of Occupational
Health, School of Public Health, Shahroud University of Medical Sciences, Shahroud, Iran, 17 Department of
Community Health Sciences, Aga Khan University, Karachi, Pakistan, 18 Department of Medical Education
and Health Sciences, Faculty of Medical Sciences, University of Sri Jayewardenepura, Gangodawila,
Nugegoda, Sri Lanka, 19 Department for Medical Research and Management for Musculoskeletal Pain,
22nd Century Medical and Research Center, Faculty of Medicine, The University of Tokyo Hospital, Tokyo,
Japan, 20 National Institute for Occupational Health, National Health Laboratory Service, Johannesburg,
South Africa, 21 Faculty of Health Sciences, University of Witwatersrand, Johannesburg, South Africa,
22 Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine,
Monash University, Melbourne, Victoria, Australia, 23 Department of Preventive and Social Medicine,
University of Otago, Dunedin, New Zealand, 24 Federal University of Paraná, Curitiba-PR, Brazil, 25 School
of Nursing of Ribeirão Preto, University of São Paulo, São Paulo, Brazil, 26 Program Health, Work and
Environment in Central America, Institute for Studies on Toxic Substances (IRET), National University of
Costa Rica, Heredia, Costa Rica, 27 Occupational Health Service, Parc de Salut MAR, Barcelona, Spain,
28 Servicio de Investigación y Análisis IT/EP, Departamento de Investigación y Análisis de Prestaciones,
MCMutual, Barcelona, Spain, 29 Department of Clinical Sciences and Community Health, Università degli
Studi di Milano, Milan, Italy, 30 Fondazione Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy,
31 Department of Psychiatry, Medical School, University of Crete, Heraklion, Greece, 32 Centre for
Research in Environmental Epidemiology (CREAL), Barcelona, Spain, 33 North Estonia Medical Centre,
Tallinn, Estonia, 34 Tartu University Hospital, Tartu, Estonia, 35 Klinikum Leverkusen, Leverkusen,
Germany, 36 Department of Physiology, Faculty of Medical Sciences, University of Sri Jayewardenepura,
Gangodawila, Nugegoda, Sri Lanka, 37 Section of Epidemiology and Biostatistics, School of Population
Health, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand,
PLOS ONE | DOI:10.1371/journal.pone.0153748 April 29, 2016 1 / 17
a11111
OPEN ACCESS
Citation: Vargas-Prada S, Coggon D, Ntani G,
Walker-Bone K, Palmer KT, Felli VE, et al. (2016)
Descriptive Epidemiology of Somatising Tendency:
Findings from the CUPID Study. PLoS ONE 11(4):
e0153748. doi:10.1371/journal.pone.0153748
Editor: Carlos M. Isales, Georgia Regents University,
UNITED STATES
Received: December 16, 2015
Accepted: April 4, 2016
Published: April 29, 2016
Copyright: This is an open access article, free of all
copyright, and may be freely reproduced, distributed,
transmitted, modified, built upon, or otherwise used
by anyone for any lawful purpose. The work is made
available under the Creative Commons CC0 public
domain dedication.
Data Availability Statement: All relevant data are
within the paper and its Supporting Information files.
Funding: Monash University funded data collection
in Australia through its grant schemes; National
Health and Medical Research Council (Australia)
supported HLK and DMU through fellowships; the
Ministry of Higher Education in Malaysia supported
VCWH in Australia; and the Health Research Council
of New Zealand funded data collection in New
Zealand. Data collection in Central America and
Colombia was supported by the Southwest Center for
Occupational and Environmental Health at the
University of Texas Health Science Center research
38 Department of Epidemiology, School of Public Health, University of Alabama at Birmingham, Birmingham,
Alabama, United States of America, 39 Faculty of Medicine, University of Kalaniya, Kelaniya, Sri Lanka,
40 Department of Joint Disease Research, 22nd Century Medical and Research Center, University of Tokyo,
Tokyo, Japan, 41 Centre for Occupational and Environmental Health, Department of Social and Preventive
Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia, 42 Injury Prevention Research
Unit, Department of Preventive and Social Medicine, University of Otago, Dunedin, New Zealand, 43 Health
Safety and Environment Department, AkzoNobel, Houston, Texas, United States of America
* dnc@mrc.soton.ac.uk
Abstract
Somatising tendency, defined as a predisposition to worry about common somatic symp-
toms, is importantly associated with various aspects of health and health-related behaviour,
including musculoskeletal pain and associated disability. To explore its epidemiological
characteristics, and how it can be specified most efficiently, we analysed data from an inter-
national longitudinal study. A baseline questionnaire, which included questions from the
Brief Symptom Inventory about seven common symptoms, was completed by 12,072 partic-
ipants aged 20–59 from 46 occupational groups in 18 countries (response rate 70%). The
seven symptoms were all mutually associated (odds ratios for pairwise associations 3.4 to
9.3), and each contributed to a measure of somatising tendency that exhibited an exposure-
response relationship both with multi-site pain (prevalence rate ratios up to six), and also
with sickness absence for non-musculoskeletal reasons. In most participants, the level of
somatising tendency was little changed when reassessed after a mean interval of 14
months (75% having a change of 0 or 1 in their symptom count), although the specific symp-
toms reported at follow-up often differed from those at baseline. Somatising tendency was
more common in women than men, especially at older ages, and varied markedly across
the 46 occupational groups studied, with higher rates in South and Central America. It was
weakly associated with smoking, but not with level of education. Our study supports the use
of questions from the Brief Symptom Inventory as a method for measuring somatising ten-
dency, and suggests that in adults of working age, it is a fairly stable trait.
Introduction
Somatising tendency is a predisposition to be unusually aware of, and to worry about, common
somatic symptoms [1]. It can be measured through instruments such as the Somatic Symptom
Scale [2], the Modified Somatic Perception Questionnaire [3], and a scale derived from the
Brief Symptom Inventory [4], and is associated with various aspects of health and health-
related behaviour. These include musculoskeletal pain [5–8], especially at multiple sites [9–15],
sickness absence from work [16,17], medical consultation [18] and dissatisfaction with medical
care [18]. Moreover, the relationship to pain has been observed in longitudinal as well as cross-
sectional studies, indicating that tendency to somatise predicts, and is not simply a conse-
quence of, other aspects of health [4–8,14,19,20].
In view of its potential to explain differences in health and behaviour, it is important to
understand better the nature of somatising tendency and its descriptive epidemiology. It would
be helpful to establish: i) how it can be assessed most efficiently (avoiding redundant informa-
tion); ii) whether it should be viewed as a long-term trait or a variable state; iii) how it relates to
personal characteristics such as sex, age and level of education; and iv) whether it varies
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importantly between countries and cultures. To explore these questions, we used data from the
Cultural and Psychosocial Influences on Disability (CUPID) study, a large international longi-
tudinal investigation of musculoskeletal pain and its determinants [21].
Methods
The design of the CUPID study and its methods of data collection have been reported in detail
elsewhere [21]. In brief, the study sample comprised a total of 12,426 participants aged 20–59
years from 47 occupational groups in 18 countries. The occupational groups fell into three
broad categories–nurses (including nursing assistants), office staff who regularly used comput-
ers, and other workers (mainly manual employees carrying out repetitive tasks with their
hands or arms). Each of the 12,426 participants completed a baseline questionnaire (either by
self-administration, or in some occupational groups at interview), representing an overall
response rate of approximately 70% among those who were eligible for inclusion [21]. After a
mean interval of 14 months (range 3–35 months, 84% within 11–19 months), participants in
45 of the 47 occupational groups (n = 11,992) were asked to complete a shorter follow-up ques-
tionnaire, and responses were obtained from 9,305 (78%).
The questionnaires were originally drafted in English, and were then translated into local
languages where necessary, accuracy being checked by independent back-translation. Among
other things, the baseline questionnaire covered sex; age; age of completing full-time education;
smoking habits; experience of pain in the past month at each of ten anatomical sites (low back;
neck; and right and left shoulder, elbow, wrist/hand and knee) illustrated by diagrams; duration
of sickness absence in the past 12 months because of illness other than a problem with the
back, neck, upper limb or knees; and somatising tendency.
Somatising tendency was assessed through questions taken from the Brief Symptom Inven-
tory [4], which asked how distressed or bothered (on a five-point ordinal scale from “not at all”
to “extremely”) the participant had been during the past seven days by each of: faintness or diz-
ziness, pains in the heart or chest, nausea or upset stomach, trouble getting breath, numbness
or tingling in parts of the body, feeling weak in parts of the body, and hot or cold spells. A
symptom was deemed to occur if it was at least moderately distressing (i.e. in the highest three
of the five levels). The same questions were asked both at baseline and at follow-up.
Statistical analysis was carried out with Stata (StataCorp LP 2012, Stata Statistical Software:
Release 12.1, College Station, Texas, USA). Pairwise associations between somatic symptoms at
baseline were summarised by odds ratios adjusted for sex and age, as were those between symp-
toms at baseline and at follow-up.
To explore the clustering of symptoms within individuals, we compared the frequency with
which a given number of symptoms was reported with the frequency that would have been
expected given the overall prevalence of each symptom, and assuming that their occurrence
was mutually independent (for example, that experience of chest pain did not make it more or
less likely that an individual would suffer from numbness or tingling). Within each of eight
strata defined by combinations of sex and 10-year age band, the expected frequency of each
possible combination of symptoms was calculated. These expected frequencies were then
summed for combinations representing the same total number of symptoms, and the totals fur-
ther summed across the eight strata to give the overall number of participants who would be
expected to have that number of symptoms.
The relationship of different counts of somatic symptoms to multi-site pain in the past
month (defined as pain at4 of 10 anatomical sites) was assessed by Poisson regression, with
adjustment for sex and age. Possible clustering of the pain outcome by occupational group was
taken into account by random intercept, multi-level modelling. Associations were summarised
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by prevalence rate ratios (PRRs) with 95% confidence intervals (95%CIs) based on robust stan-
dard errors. To explore whether somatising tendency could be adequately characterised with-
out asking about all seven symptoms, we repeated the analysis, excluding data on specific
symptoms in turn, and compared population attributable fractions (PAFs–defined as the pro-
portions of cases in a population that would be eliminated if all people had the same risk as
those in the reference category). Confidence intervals for PAFs were derived by bootstrapping.
To check that findings were not specific to associations with multi-site pain, we repeated the
analyses with an alternative outcome–absence from work for>5 days in the past year for rea-
sons other than a problem with the back, neck, upper limb or knees.
We used simple descriptive statistics to summarise changes in the occurrence of somatic
symptoms from baseline to follow-up, and the prevalence of symptoms by occupational group.
To test whether there was greater similarity in the occurrence of symptoms within as compared
to between countries, we calculated the intra-class correlation coefficient (ICC) for the mean
numbers of symptoms by occupational group.
We also investigated the possibility that some occupational groups might have a different
profile of somatic symptoms from others. For each combination of occupational group and
symptom, we compared the number of participants in the group who reported the symptom,
with the number that would have been expected to report it if, after allowance for sex and age,
the frequency of the symptom as a proportion of all symptom reports in the occupational
group were the same as that in the full study sample. A ratio of observed to expected greater
than one was an indication that the occupational group experienced the symptom more often
than would have been expected, given their overall tendency to somatise.
Finally, we used Poisson regression to assess the (mutually adjusted) cross-sectional associa-
tions of somatising tendency at baseline (defined as report of3 somatic symptoms) with pos-
sible risk factors (sex, age, smoking habits and age finished full-time education). Again random
intercept modelling was used to allow for possible clustering by occupational group.
Ethical approval for the study was provided by the relevant research ethics committee or
institutional review board in each participating country (S1 Appendix).
Results
In one occupational group (office workers in Colombia), one of the questions about somatic
symptoms had been omitted. Complete data on somatic symptoms at baseline were available
for 12,072 men and women from the remaining 46 occupational groups (98% of all participants
from those groups). Table 1 shows the prevalence of each symptom by sex and age. Among
men, the prevalence of all symptoms except numbness or tingling was highest in the youngest
age group (20–29 years). Women reported each of the seven symptoms more frequently than
men, and particularly nausea or upset stomach, hot or cold spells (especially at older ages), and
numbness or tingling (again more at older ages). Moreover, in contrast to men, the only symp-
toms that were most common at age 20–29 years were faintness or dizziness and nausea or
upset stomach. In view of these differences, all subsequent analyses were adjusted for sex and
age.
Table 2 summarises the associations between pairs of somatic symptoms at baseline. The
strongest associations were for pain in the heart or chest with trouble getting breath (OR 9.3),
and feeling weak in parts of the body with numbness or tingling in parts of the body (OR 7.9).
However, all symptoms were associated with each other, the lowest odds ratio being 3.4.
Table 3 compares the frequency with which specified numbers of symptoms were reported
and the frequency that would have been expected had the occurrence of each symptom been
statistically independent. More participants than expected reported no symptoms at all (6,016
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vs. 3,433). However, there were fewer than expected with 1–3 symptoms. The ratio of observed
to expected numbers then increased progressively for report of larger numbers of symptoms,
rising from 2.75 for four symptoms to 2000 for all seven symptoms.
Table 3 also shows the associations between the number of somatic symptoms and report of
pain at4 of 10 anatomical sites. Relative to no somatic symptoms, PRRs for multisite pain
increased progressively from 2.3 (95%CI 2.0–2.7) for one somatic symptom to 5.9 (95%CI 4.8–
7.4) for five somatic symptoms, and then remained at a similar level for six and seven symp-
toms. The right-hand columns of the table give the corresponding population attributable frac-
tions (PAFs) and their 95% CIs. Overall, report of at least one somatic symptom accounted for
59.0% of the cases of multi-site pain in the study sample.
To explore whether information about any of the somatic symptoms was effectively redun-
dant, we repeated the analysis of associations with multi-site pain excluding each of the seven
symptoms in turn (Table 4). In each case, the PAF for multi-site pain that was associated with
report of at least one of the remaining somatic symptoms was lower than in the analysis that
included all somatic symptoms (53.2% to 58.6% vs. 59.0%), indicating that each symptom
added to the characterisation of somatising tendency, although an index based on only six of
the seven symptoms would still work well.
Table 1. Baseline prevalence (%) of distressing somatic symptoms in past 7 days by sex and age.
Symptom Men Women
20–29 years 30–39 years 40–49 years 50–59 years 20–29 years 30–39 years 40–49 years 50–59 years
(N = 1,056) (N = 1,379) (N = 1,170) (N = 641) (N = 1,954) (N = 2,487) (N = 2,172) (N = 1,213)
Faintness or dizziness 8.0 (85) 7.2 (99) 6.2 (73) 4.8 (31) 17.3 (339) 15.9 (395) 15.1 (328) 12.0 (146)
Pains in heart or chest 10.1 (107) 7.0 (97) 5.8 (68) 5.8 (37) 9.6 (188) 10.0 (248) 12.4 (269) 10.8 (131)
Nausea or upset stomach 16.3 (172) 12.8 (177) 11.4 (133) 9.7 (62) 27.0 (528) 25.3 (630) 22.9 (497) 18.3 (222)
Trouble getting breath 7.1 (75) 5.7 (79) 5.6 (65) 5.5 (35) 10.1 (197) 10.0 (149) 10.6 (230) 10.2 (124)
Hot or cold spells 16.7 (176) 11.8 (163) 10.8 (126) 9.8 (63) 21.6 (423) 21.5 (535) 26.9 (584) 35.1 (426)
Feeling weak in parts of your
body
21.3 (225) 17.3 (238) 18.9 (221) 18.6 (119) 26.7 (522) 30.7 (763) 30.9 (671) 28.3 (343)
Numbness or tingling in parts
of your body
14.8 (156) 11.6 (160) 16.0 (187) 14.8 (95) 17.2 (336) 25.0 (621) 30.8 (670) 29.6 (359)
Figures in brackets are the numbers of participants with the relevant symptom
doi:10.1371/journal.pone.0153748.t001
Table 2. Pairwise associations between specific somatic symptoms at baseline.
Symptom at baseline Faintness or
dizziness
Pains in heart
or chest
Nausea or upset
stomach
Trouble getting
breath
Hot or cold
spells
Feeling weak in
parts of body
Pains in heart or chest 6.6 (492)
Nausea or upset stomach 5.8 (802) 4.5 (587)
Trouble getting breath 5.6 (429) 9.3 (450) 4.4 (547)
Hot or cold spells 4.0 (706) 3.4 (548) 3.8 (1,050) 4.1 (544)
Feeling weak in parts of
body
5.1 (874) 4.7 (681) 3.9 (1,249) 4.9 (653) 4.9 (1,365)
Numbness or tingling in
parts of body
3.9 (705) 4.4 (607) 3.4 (1,032) 4.7 (587) 3.6 (1,113) 7.9 (1,625)
Associations are summarised by odds ratios adjusted for sex and age, with the number of participants reporting both symptoms in brackets
doi:10.1371/journal.pone.0153748.t002
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To check that these patterns of association were not specific to pain outcomes, we repeated
the analyses for Tables 3 and 4, taking as an alternative outcome sickness absence in the past 12
months for non-musculoskeletal reasons. In the analysis that included all seven somatic symp-
toms, PRRs rose progressively from 1.4 (95%CI 1.1–1.7) for report of one symptom to 3.2
(95%CI 2.4–4.2) for report of seven symptoms, and the PAF for report of at least one somatic
symptom was 30.4% (Table 5). The PAFs when single somatic symptoms were disregarded
ranged from 27.1% to 30.4% (Table 6).
Complete information about somatic symptoms at follow-up was available for 8,856 (73%)
of the participants who provided satisfactory information at baseline, the follow-up rate being
similar in those who initially did and did not have symptoms. Table 7 shows the number of
somatic symptoms that they reported at follow-up, according to the number that were present
at baseline. In general, participants reported similar numbers of symptoms at follow-up as at
baseline, 6,677 (75%) having a change of zero or one in their symptom count. There were, how-
ever, notable exceptions. In particular, seven participants went from zero symptoms at baseline
to seven at follow-up, and 19 changed to the same extent in the reverse direction. More detailed
examination of the questionnaire responses for these 26 individuals indicated that for the most
part, the changes represented substantial differences in the levels of distress reported from indi-
vidual symptoms, and not simply a shift from their being “a little bit” to “moderately”
distressing.
The 8,856 participants who provided complete information at both time-points reported a
total of 10,326 somatic symptoms at baseline. Of these specific symptoms, 3,733 (36%) were
Table 3. Observed and expected frequency of multiple somatic symptoms and associations with multi-site pain.
Number of
somatic
symptoms
Observed
number of
subjects
Expected
number of
subjectsa
Ratio of
observed to
expected
Association with pain at 4 vs. 0 anatomical sites
Number with
no pain
Number with
pain at 4
sites
PRRb (95%
CI)
PAFc
(%)
(95%
CI)
0 6,016 3,433 1.75 3,125 374 1
1 2,312 4,546 0.51 779 291 2.3 (2.0–
2.7)
8.9 (6.8–
11.0)
2 1,551 2,817 0.55 336 342 4.0 (3.3–
4.8)
13.7 (11.5–
15.8)
3 944 1,020 0.93 149 295 5.0 (4.1–
6.1)
12.6 (10.7–
14.6)
4 618 224.6 2.75 86 226 5.1 (4.1–
6.5)
9.7 (7.6–
11.7)
5 326 29.26 11.1 30 164 5.9 (4.8–
7.4)
7.3 (5.5–
9.1)
6 185 2.058 89.9 14 104 6.0 (4.6–
7.7)
4.6 (3.2–
6.0)
7 120 0.060 2000 15 78 5.8 (4.6–
7.2)
3.4 (2.2–
4.7)
1 6,056 8,639.18 0.70 1,409 1,500 3.8 (3.2–
4.5)
59.0 (53.5–
64.5)
3 2,193 1,276.23 1.72 294 867 5.6 (4.4–
7.0)
37.9 (30.9–
44.9)
a Expected number given the overall prevalence of each symptom, and assuming no association between the occurrence of one symptom and another
after allowance for sex and age (in four 10-year strata)
b Prevalence rate ratio adjusted for sex and age (in four 10-year strata)
c Population attributable fraction
doi:10.1371/journal.pone.0153748.t003
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again reported at follow-up, while 6,593 (64%) had resolved. On the other hand, 4,123 (52%) of
a total of 7,856 symptoms at follow-up were new since baseline. Table 8 summarises the pair-
wise associations between specific somatic symptoms at baseline and at follow-up. The highest
Table 4. Associations of multiple somatic symptomswith multi-site pain when one of the seven somatic symptomswas ignored.
Somatic symptom
disregarded
Number of somatic symptoms
1 2 3 4 5 6 1 somatic symptom
PRRa (95%
CI)
PRRa (95%
CI)
PRRa (95%
CI)
PRRa (95%
CI)
PRRa (95%
CI)
PRRa (95%
CI)
PRRa (95%
CI)
PAFb
(%)
Faintness or dizziness 2.4 (2.1–
2.8)
3.9 (3.3–
4.7)
5.1 (4.2–
6.3)
5.2 (4.2–
6.5)
5.8 (4.6–
7.5)
5.7 (4.6–
7.1)
3.7 (3.2–
4.4)
57.6
Pains in heart or chest 2.5 (2.1–
2.9)
4.1 (3.4–
5.0)
5.0 (4.1–
6.2)
5.4 (4.3–
6.8)
5.8 (4.5–
7.4)
5.9 (4.7–
7.3)
3.8 (3.2,
4.5)
58.6
Nausea or upset
stomach
2.5 (2.1–
3.0)
4.2 (3.5–
5.0)
4.8 (3.9–
5.9)
5.5 (4.4–
6.8)
5.6 (4.4–
7.1)
5.4 (4.4–
6.7)
3.8 (3.2–
4.4)
57.0
Trouble getting breath 2.4 (2.1–
2.7)
4.1 (3.4–
5.0)
5.0 (4.1–
6.0)
5.3 (4.3–
6.6)
6.1 (4.8–
7.7)
5.8 (4.6–
7.2)
3.8 (3.2–
4.4)
58.6
Hot or cold spells 2.5 (2.2–
3.0)
4.3 (3.6–
5.2)
4.8 (3.8–
6.0)
5.3 (4.2–
6.7)
5.6 (4.4–
7.1)
5.1 (4.0–
6.5)
3.8 (3.2–
4.5)
56.7
Feeling weak in parts
of your body
2.5 (2.1–
2.9)
3.7 (3.1–
4.3)
4.3 (3.6–
5.2)
4.7 (3.8–
5.8)
5.1 (4.1–
6.5)
4.8 (3.9–
5.9)
3.3 (2.9–
3.9)
53.2
Numbness or tingling
in parts of your body
2.5 (2.2–
2.9)
3.8 (3.2–
4.6)
4.2 (3.5–
5.1)
4.8 (3.9–
6.0)
4.8 (3.9–
6.0)
5.1 (4.0–
6.3)
3.4 (3.0–
4.0)
54.4
a Prevalence rate ratio, adjusted for sex and age (in four 10-year strata), for pain at 4 vs. 0 anatomical sites in participants with the speciﬁed number of
somatic symptoms compared with no somatic symptoms. The speciﬁed number of symptoms was from the total of six that remained when the symptom in
the left-hand column was disregarded.
b Population attributable fraction
doi:10.1371/journal.pone.0153748.t004
Table 5. Associations between number of somatic symptoms and sickness absence for >5 days in past 12 months for non-musculoskeletal
reasons.
Number of somatic symptoms Duration of sickness absence in past 12 months for reasons other than musculoskeletal pain
None >5 days
N N PRRa (95%CI) PAFb (%) (95%CI)
0 3,982 408 1
1 1,377 225 1.4 (1.1–1.7) 5.1 (2.3–7.9)
2 863 200 1.8 (1.6–2.2) 7.7 (5.8–9.6)
3 453 135 2.3 (1.8–2.8) 6.3 (4.4–8.2)
4 266 104 2.8 (2.2–3.4) 5.5 (3.5–7.6)
5 154 60 2.7 (2.1–3.5) 3.2 (1.7–4.7)
6 70 34 2.9 (2.0–4.1) 1.9 (0.8–2.9)
7 44 28 3.2 (2.4–4.2) 1.6 (0.7–2.5)
1 3,227 786 1.9 (1.6–2.2) 30.4 (23.9–36.9)
3 987 361 2.5 (2.1–3.1) 18.4 (10.9–25.8)
a Prevalence rate ratio relative to no sickness absence in past 12 months for non-musculoskeletal reasons, adjusted for sex and age (in four 10-year
strata)
b Population attributable fraction
doi:10.1371/journal.pone.0153748.t005
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odds ratios (3.6 to 6.6) were for continuing presence of the same symptom at follow-up as at
baseline, but all odds ratios were1.6, and most were2.0.
Fig 1 shows the prevalence of different numbers of somatic symptoms at baseline by occu-
pational group. There was major variation between the groups–for example, the prevalence of
3 somatic symptoms ranged from 1.3% among office workers in Pakistan and 4.2% in sugar
cane cutters in Brazil to 38.1% in office workers in Costa Rica and 51.8% in manual workers in
Costa Rica. Apart from the Brazilian sugar cane cutters, rates in South and Central America
were all relatively high. The mean numbers of symptoms by occupational group showed
greater similarity within than between countries (ICC = 15%). However, there was no consis-
tent pattern by type of occupation (nurse, office worker or other).
Table 6. Associations of multiple somatic symptomswith sickness absence for >5 days in past 12 months for non-musculoskeletal reasons when
one of the seven somatic symptomswas ignored.
Somatic symptom
disregarded
Number of somatic symptoms
1 2 3 4 5 6 1 somatic symptom
PRRa (95%
CI)
PRRa (95%
CI)
PRRa (95%
CI)
PRRa (95%
CI)
PRRa (95%
CI)
PRRa (95%
CI)
PRRa (95%
CI)
PAFb
(%)
Faintness or dizziness 1.4 (1.2–
1.6)
2.0 (1.7–
2.3)
2.4 (1.9–
3.0)
2.4 (1.9–
3.1)
2.8 (2.1–
3.8)
3.0 (2.3–
3.9)
1.8 (1.6–
2.1)
29.3
Pains in heart or chest 1.4 (1.2–
1.7)
1.8 (1.6–
2.1)
2.3 (1.9–
2.8)
2.8 (2.2–
3.5)
2.6 (2.0–
3.3)
3.6 (2.7–
4.9)
1.8 (1.6–
2.2)
29.6
Nausea or upset
stomach
1.4 (1.2–
1.7)
1.9 (1.6–
2.2)
2.4 (2.0–
2.9)
2.7 (2.1–
3.4)
2.6 (1.9–
3.6)
2.9 (2.1–
3.9)
1.8 (1.6–
2.1)
28.0
Trouble getting breath 1.4 (1.2–
1.6)
1.9 (1.6–
2.2)
2.1 (1.7–
2.7)
2.7 (2.2–
3.3)
2.9 (2.1–
3.8)
2.9 (2.1–
3.9)
1.8 (1.6–
2.1)
29.4
Hot or cold spells 1.6 (1.3–
1.8)
2.0 (1.7–
2.3)
2.5 (2.0–
3.1)
2.7 (2.1–
3.5)
2.9 (2.2–
3.9)
2.9 (2.2–
3.8)
2.0 (1.7–
2.3)
30.4
Feeling weak in parts
of your body
1.4 (1.2–
1.6)
1.9 (1.6–
2.3)
2.4 (2.0–
3.0)
2.9 (2.3–
3.6)
3.0 (2.1–
4.1)
2.9 (2.2–
3.8)
1.8 (1.6–
2.1)
27.1
Numbness or tingling
in parts of your body
1.5 (1.2–
1.7)
2.0 (1.7–
2.3)
2.7 (2.3–
3.3)
2.6 (2.1–
3.3)
2.5 (1.7–
3.7)
3.1 (2.4–
4.0)
1.9 (1.6–
2.2)
29.5
a Prevalence rate ratio, adjusted for sex and age (in four 10-year strata), for sickness absence in the past 12 months for non-musculoskeletal reasons vs.
0 days of sickness absence in participants with the speciﬁed number of somatic symptoms compared with no somatic symptoms. The speciﬁed number of
symptoms was from the total of six that remained when the symptom in the left-hand column was disregarded.
b Population attributable fraction
doi:10.1371/journal.pone.0153748.t006
Table 7. Number of somatic symptoms reported at follow-up according to number of somatic symptoms reported at baseline.
Number of symptoms at baseline Number of symptoms at follow-up
0 1 2 3 4 5 6 7
0 3,329 622 235 107 49 18 10 7
1 885 479 216 108 47 15 2 0
2 452 293 217 101 52 21 12 2
3 230 151 137 98 54 16 14 4
4 141 71 81 75 47 29 19 5
5 51 31 40 41 26 17 7 5
6 20 12 18 16 13 16 9 5
7 19 13 5 10 5 11 8 7
Analysis was restricted to the 8,856 participants who provided complete information about somatic symptoms at both baseline and follow-up.
doi:10.1371/journal.pone.0153748.t007
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To explore whether any occupational groups displayed a distinct profile of somatic symp-
toms, we compared the proportionate frequency of specific symptoms after standardisation for
sex and age. The standardised proportions ranged from 0 for hot or cold spells in Brazilian
sugar cane cutters and 0.15 for hot or cold spells in Sri Lankan postal workers to 1.98 for nausea
or upset stomach in Japanese sales personnel and 2.10 for hot or cold spells in Pakistani postal
workers. However, the large majority were between 0.67 and 1.5. The most salient patterns by
country were high ratios for trouble getting breath in Brazil (1.28–1.56); low ratios for hot or
cold spells in Greece (0.37–0.73); high ratios for faintness or dizziness (1.73 and 1.75) and low
ratios for feeling weak (0.31 and 0.49) in Estonia; low ratios for pains in the heart or chest in
Lebanon (0.42–0.63); low ratios for each of faintness or dizziness (0.58–0.72), pains in the
heart or chest (0.23–0.78) and trouble getting breath (0.28–0.80), and high ratios for hot or
cold spells (1.44–2.10) in Pakistan; high ratios for nausea or upset stomach (1.17–1.98) and low
ratios for trouble getting breath (0.24–0.53) in Japan; and high ratios for pains in the heart or
chest in South Africa (1.57 and 1.77). Further details are given in Table 9.
In a mutually adjusted analysis of the cross-sectional association between personal charac-
teristics and somatising tendency (pragmatically specified as report of3 somatic symptoms),
there was a significantly elevated risk with female sex (PRR 1.8, 95%CI 1.5–2.1), and a weak
but significant relationship to smoking habits (PRRs of 1.3 and 1.2 for current and ex- as com-
pared with non-smokers). However, there was no association with age of finishing full-time
education (data not shown).
Discussion
Within our large study sample, the seven somatic complaints that we examined were all mutu-
ally associated, such that report of multiple symptoms was much more frequent than would
have been expected had their occurrence been unrelated. However, no cut-point in the number
Table 8. Pairwise associations between specific somatic symptoms at baseline and at follow-up.
Symptom at baseline Symptom at follow-up
Faintness or
dizziness
Pains in
heart or
chest
Nausea or
upset stomach
Trouble
getting
breath
Hot or cold
spells
Feeling weak in
parts of body
Numbness or
tingling in parts of
body
(n = 741) (n = 542) (n = 1,254) (n = 558) (n = 1,445) (n = 1,778) (n = 1,538)
Faintness or dizziness
(n = 1,030)
5.0 (293) 2.6 (149) 2.4 (295) 2.1 (133) 2.1 (304) 2.3 (377) 2.5 (351)
Pains in heart or chest
(n = 753)
2.6 (155) 5.6 (182) 2.0 (196) 2.6 (115) 1.8 (216) 2.0 (264) 2.1 (252)
Nausea or upset
stomach (n = 1,719)
2.6 (287) 2.0 (190) 3.6 (545) 1.7 (179) 1.6 (421) 2.0 (556) 1.7 (462)
Trouble getting breath
(n = 748)
2.6 (148) 3.2 (132) 2.1 (202) 6.6 (199) 1.8 (215) 2.3 (286) 2.2 (253)
Hot or cold spells
(n = 1,833)
2.2 (285) 2.1 (219) 2.0 (438) 1.9 (208) 3.9 (709) 2.1 (620) 2.0 (557)
Feeling weak in parts
of body (n = 2,317)
2.6 (361) 2.4 (263) 2.1 (538) 2.2 (265) 2.0 (611) 4.3 (983) 2.9 (760)
Numbness or tingling
in parts of body
(n = 1,926)
2.5 (306) 2.7 (249) 2.0 (452) 1.9 (220) 1.9 (534) 2.7 (729) 5.1 (822)
Associations are summarised by odds ratios adjusted for sex and age (in 10-year strata), with the number of participants reporting both symptoms in
brackets. Analysis was restricted to the 8,856 participants who provided complete information about somatic symptoms at both baseline and follow-up.
doi:10.1371/journal.pone.0153748.t008
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Fig 1. Frequency of somatic symptoms by occupational group.
doi:10.1371/journal.pone.0153748.g001
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Table 9. Standardised proportions of specific symptoms by occupational group.
Occupational
group
Symptom
Faintness or
dizziness
Pains in
heart or
chest
Nausea or
upset stomach
Trouble
getting
breath
Hot or
cold
spells
Feeling weak in
parts of your body
Numbness or tingling in
parts of your body
Brazil
Nurses 0.58 1.03 0.77 1.28 0.80 1.06 1.43
Ofﬁce workers 0.60 1.43 0.69 1.56 0.89 0.94 1.21
Other workers 1.32 1.27 0.72 1.54 0.00 0.83 1.89
Ecuador
Nurses 1.13 0.94 1.00 0.63 1.29 0.96 0.84
Ofﬁce workers 0.63 1.17 1.08 0.87 1.05 1.02 1.05
Other workers 1.06 1.37 0.91 1.12 1.11 0.98 0.75
Costa Rica
Nurses 0.56 0.94 1.01 0.92 1.12 1.02 1.16
Ofﬁce workers 0.71 1.02 1.12 1.16 1.15 0.83 1.04
Other workers 0.96 1.18 0.88 1.03 0.90 0.95 1.20
Nicaragua
Nurses 0.78 0.80 1.03 0.89 1.12 0.91 1.19
Ofﬁce workers 0.70 1.04 0.89 1.17 1.12 0.95 1.15
Other workers 0.53 0.54 0.83 1.52 1.23 1.07 1.16
UK
Nurses 0.92 1.28 1.13 0.75 1.18 0.90 0.86
Ofﬁce workers 1.05 1.06 1.05 1.08 1.05 0.96 0.88
Other workers 1.31 1.14 1.00 1.12 1.07 0.95 0.75
Spain
Nurses 0.73 0.52 0.93 0.76 0.64 1.56 1.23
Ofﬁce workers 0.66 0.56 0.89 0.88 1.17 1.24 1.09
Italy
Nurses 1.16 1.06 1.24 1.18 0.87 0.88 0.86
Other workers 0.94 0.87 0.96 1.44 0.83 1.05 1.06
Greece
Nurses 1.22 0.74 0.98 0.93 0.37 1.20 1.34
Ofﬁce workers 1.08 1.18 0.96 0.63 0.73 1.11 1.19
Other workers 1.39 0.91 0.81 1.45 0.58 1.10 1.05
Estonia
Nurses 1.75 1.77 0.84 1.15 1.03 0.49 0.90
Ofﬁce workers 1.73 1.29 0.91 1.96 0.95 0.31 1.01
Lebanon
Nurses 1.07 0.42 1.35 1.14 0.63 1.13 0.96
Ofﬁce workers 0.71 0.48 1.25 1.68 0.57 1.15 1.11
Other workers 0.95 0.63 0.70 1.44 1.21 0.89 1.29
Iran
Nurses 1.50 1.32 0.84 1.23 0.90 1.01 0.68
Ofﬁce workers 1.86 1.05 0.38 0.74 1.40 1.00 0.79
Pakistan
Nurses 0.58 0.36 0.50 0.36 1.44 1.47 1.54
Ofﬁce workers 0.64 0.23 0.83 0.28 1.86 1.43 0.68
Other workers 0.72 0.78 0.72 0.80 2.10 1.09 0.57
(Continued)
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of reported symptoms distinguished unequivocally between people with and without a soma-
tising syndrome. Rather, there appeared to be a gradation in degrees of tendency to somatise.
In most individuals, the level of somatising tendency (as assessed by the questionnaire) was lit-
tle changed after a follow-up interval of approximately 14 months, although the specific symp-
toms reported at follow-up often differed from those at baseline. Tendency to somatise was
more common in women than men, especially at older ages, and after allowance for sex and
age, it varied markedly across the 46 occupational groups studied, with greater similarities
within than between countries. It was weakly associated with smoking, but not with level of
education.
As well as the size, geographical spread and cultural diversity of the study sample, our inves-
tigation benefitted from high response rates. However, it was limited to adults of working age,
and the findings cannot necessarily be extrapolated to other age groups. It was also restricted to
selected occupational groups, although apart perhaps from sugar cane cutters in Brazil, it
seems unlikely that these will have been highly unrepresentative of the wider working popula-
tions in participating countries.
Table 9. (Continued)
Occupational
group
Symptom
Faintness or
dizziness
Pains in
heart or
chest
Nausea or
upset stomach
Trouble
getting
breath
Hot or
cold
spells
Feeling weak in
parts of your body
Numbness or tingling in
parts of your body
Sri Lanka
Nurses 1.07 0.67 1.08 1.51 1.41 0.64 0.80
Ofﬁce workers 0.76 1.11 1.01 0.87 1.33 0.72 1.18
Other workers
(1)
0.83 1.26 0.80 0.99 0.15 1.40 1.20
Other workers
(2)
0.82 1.59 1.05 0.79 1.15 0.95 0.79
Japan
Nurses 1.38 0.87 1.56 0.53 0.90 0.85 0.66
Ofﬁce workers 1.70 0.80 1.25 0.24 1.14 0.84 0.88
Other workers
(1)
1.34 0.80 1.17 0.42 0.94 1.13 0.91
Other workers
(2)
1.13 0.68 1.98 0.35 1.05 0.84 0.56
South Africa
Nurses 1.20 1.57 0.83 1.16 1.06 0.83 0.88
Ofﬁce workers 1.04 1.77 1.06 1.22 0.98 0.71 0.84
Australia
Nurses 1.08 0.49 1.33 1.03 0.87 1.07 0.92
New Zealand
Nurses 0.90 1.09 1.15 0.49 1.21 0.97 0.91
Ofﬁce workers 0.62 0.58 1.36 0.83 1.12 1.05 0.97
Other workers 0.84 0.85 1.05 0.92 1.08 1.15 0.88
Standardised proportions were calculated as O/∑i(ni * Si/Ni) where O was the observed frequency of the speciﬁed symptom in the occupational group,
and within the ith of 8 strata of sex and 10-year age band, ni was the total number of symptom reports (any of the seven symptoms) in the occupational
group, Si was the number of reports of the speciﬁed symptom in all occupational groups combined, and Ni was the total number of symptom reports (any
of the seven symptoms) in all occupational groups combined.
doi:10.1371/journal.pone.0153748.t009
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Somatising tendency was assessed through seven questions taken from the Brief Symptom
Inventory, which has been established as a valid and reliable instrument [22] with the ability to
predict future health outcomes in longitudinal investigations [6–8]. Moreover, where it was
necessary to translate the questionnaire into local languages, care was taken to check accuracy
through independent back-translation. Nevertheless, it is possible that symptoms were under-
stood differently across varied cultural settings. Such variation may have contributed to differ-
ences in prevalence between countries, but would not explain associations with other variables
measured at individual level in analyses that adjusted for possible clustering by job group.
We did not have information about personality traits or about other medical conditions
such as cancer, which may have caused some of the symptoms that distressed participants.
However, since our study sample comprised adults in active employment, the prevalence of
serious co-morbidity will have been low, and should not have impacted importantly on our
conclusions.
Understanding of terms for pain may have varied between participants speaking different
languages, but the anatomical location of symptoms should have been unambiguous, since it
was defined pictorially. Errors of interpretation are less likely to have occurred for other vari-
ables such as history of sickness absence, smoking habits and educational level, although they
may have been liable to inaccurate recall. Provided inaccuracies were not differential in relation
to somatising tendency, any resultant bias in associations with somatising tendency will have
been towards the null.
Much of the literature on somatisation has focused on medically unexplained somatic
symptoms as a reason for presentation to medical care, and a manifestation of hidden psychiat-
ric morbidity. As defined in the tenth revision of the International Classification of Diseases
(ICD10), somatisation disorder is generally infrequent, with prevalence rates among adults
aged 18–65 years in a cross-cultural study of 14 countries mostly less than 2% [23]. However,
our interest was in the wider spectrum of distress from common somatic symptoms, not neces-
sarily leading to medical consultation of themselves, but collectively associated with other
aspects of health and health-related behaviour. By limiting our enquiry to symptoms in the
past week, we reduced the potential for errors in recall, which can be a problem when longer
periods are considered [24].
Our results confirm that report of multiple distressing somatic symptoms constitutes a syn-
drome, the co-occurrence of symptoms being much more frequent than would be expected by
chance. However, there was no clear dichotomy between people with and without somatising
tendency. Thus, the strength of associations, both with multi-site pain and with sickness
absence for non-musculoskeletal reasons, increased progressively with the number of symp-
toms reported, at least up to five. Because these associations were cross-sectional, they cannot
necessarily be interpreted as causal, although longitudinal studies have indicated that people
who complain of common somatic symptoms are more likely to develop multisite musculo-
skeletal pain subsequently [19,20]. We also found that all seven of the symptoms investigated
contributed to the measurement of somatising tendency, with smaller attributable fractions for
multi-site pain and non-musculoskeletal sickness absence when any one of the symptoms was
disregarded. However, the differences in PAFs were generally small, and if resources were lim-
ited, it is likely that little would be lost if any one of the seven symptoms were omitted from the
question set.
Follow-up of participants after approximately 14 months demonstrated that levels of soma-
tising tendency were fairly stable within individuals over that timescale, and the observation
that this occurred despite changes in the specific symptoms reported is evidence that the con-
sistency reflects a continuing general predisposition to be aware of and report physical symp-
toms, rather than persistence of specific underlying disease. A similar pattern has been found
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in earlier longitudinal studies [24]. It is notable, however, that a small minority of participants
exhibited major changes in their degree of somatising tendency, suggesting that it is not
entirely a fixed trait, and raising the possibility that it might in some cases be amenable to inter-
vention. Another possibility is that these large changes reflected the development or resolution
of co-morbidity.
The higher frequency of somatic symptoms among women than men accords with other
studies [25–27]. It has been postulated that the imbalance may reflect innate differences in
somatic and visceral perception; differences in symptom labelling, description and reporting;
or a greater willingness of women to acknowledge and disclose discomfort [25]. It could also
arise from a higher prevalence of depression in women.
Somatisation has also been reported to occur more commonly at older ages [23]. We too
found a positive relationship to age in women, although in men, the prevalence of somatic
symptoms was highest at younger ages. Because our analysis was cross-sectional, it was not
possible to distinguish effects of age from trends across birth cohorts. However, the higher
prevalence of hot or cold flushes among older women may have been a physiological effect of
age.
The large differences between occupational groups and countries in the prevalence and
degree of somatising tendency were apparent even after adjustment for differences in sex and
age. As already discussed, the variation may have been, at least in part, a linguistic artefact.
However, earlier research using different methods has also indicated unusually high rates of
somatisation in South America [23]. In that study, there was no evidence that somatising
patients from South America had a lower prevalence of co-occurring depression or generalised
anxiety disorder, which suggests that their somatisation was not a manifestation of occult men-
tal illness. Perhaps more likely is a culturally determined difference in the perception of bodily
sensations and the importance that is attached to them, or in willingness to report them when
they occur. There was also variation between countries in the relative frequency of specific
somatic symptoms, but to a lesser extent.
Somatisation has previously been linked with an absence of formal education [23], but after
allowance for sex, age and occupational group, we found no relationship to level of education.
This may have been because within occupational groups there was too little heterogeneity for
an effect to be discernible. We did, however, find a weak association with smoking, which is
consistent with an earlier study in Finnish adolescents [28].
In summary, our study supports the use of questions from the Brief Symptom Inventory as
a method for measuring tendency to somatise, each of the seven questions contributing to its
assessment. The findings indicate that somatising tendency should be regarded as a quantifi-
able characteristic that exhibits an exposure-response relationship in its association with other
health measures, and appears to be fairly stable over an interval of approximately one year,
although the specific symptoms that individuals report frequently vary over time. It is more
common in women than in men, especially at older ages, and its prevalence varies between
countries with higher rates in South and Central America.
Given its potential to explain differences in disability and in economically important out-
comes such as sickness absence from work, there is a need to understand further what drives
somatising tendency, and whether and how it might be modified at a population level. There is
evidence, for example, that it tracks across generations [29], and it may be a trait which is
acquired early in life. Thus, there is a need for further research to establish how it evolves at
younger ages, what influences its development, and also how constant it remains over longer
follow-up periods.
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